Datta-Mannan, A., Czeskis, B., Shanks, E., Yuen, E., Hall, S., Rodriguez Cruz, V., & Cassidy, K. (2025, June 24). Disposition and Absolute Bioavailability of Oral Imlunestrant in Healthy Women: A Phase 1, Open-Label Study. Clinical pharmacology in drug development. https://doi.org/10.1002/cpdd.1562
Chicago Style (17th ed.) CitationDatta-Mannan, Amita, Boris Czeskis, Elaine Shanks, Eunice Yuen, Stephen Hall, Vivian Rodriguez Cruz, and Kenneth Cassidy. "Disposition and Absolute Bioavailability of Oral Imlunestrant in Healthy Women: A Phase 1, Open-Label Study." Clinical Pharmacology in Drug Development 24 Jun. 2025. https://doi.org/10.1002/cpdd.1562.
MLA (9th ed.) CitationDatta-Mannan, Amita, et al. "Disposition and Absolute Bioavailability of Oral Imlunestrant in Healthy Women: A Phase 1, Open-Label Study." Clinical Pharmacology in Drug Development, 24 Jun. 2025, https://doi.org/10.1002/cpdd.1562.